These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 2026752

  • 1. Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation.
    DeBell WK, Pezzoli SS, Thorner MO.
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1312-6. PubMed ID: 2026752
    [Abstract] [Full Text] [Related]

  • 2. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus.
    Huhn WC, Hartman ML, Pezzoli SS, Thorner MO.
    J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311
    [Abstract] [Full Text] [Related]

  • 3. Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men.
    Hartman ML, Farello G, Pezzoli SS, Thorner MO.
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1378-84. PubMed ID: 1592884
    [Abstract] [Full Text] [Related]

  • 4. Effects of a prolonged growth hormone (GH)-releasing peptide infusion on pulsatile GH secretion in normal men.
    Jaffe CA, Ho PJ, Demott-Friberg R, Bowers CY, Barkan AL.
    J Clin Endocrinol Metab; 1993 Dec; 77(6):1641-7. PubMed ID: 7903313
    [Abstract] [Full Text] [Related]

  • 5. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
    Shah N, Evans WS, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
    [Abstract] [Full Text] [Related]

  • 6. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.
    Anderson SM, Shah N, Evans WS, Patrie JT, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2001 Feb; 86(2):551-60. PubMed ID: 11158008
    [Abstract] [Full Text] [Related]

  • 7. Abuse of recombinant human growth hormone: studies in two different dog models.
    Rigamonti AE, Scanniffio D, Bonomo SM, Cella SG, Sartorio A, Müller EE.
    Neuroendocrinology; 2004 Feb; 79(5):237-46. PubMed ID: 15218318
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of pulsatile growth hormone secretion by continuous infusion of a growth hormone-releasing peptide mimetic, L-692,429, in older adults--a clinical research center study.
    Chapman IM, Hartman ML, Pezzoli SS, Thorner MO.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2874-80. PubMed ID: 8768844
    [Abstract] [Full Text] [Related]

  • 9. Evidence for a limited growth hormone (GH)-releasing hormone (GHRH)-releasable quantity of GH: effects of 6-hour infusions of GHRH on GH secretion in normal man.
    Vance ML, Kaiser DL, Evans WS, Thorner MO, Furlanetto R, Rivier J, Vale W, Perisutti G, Frohman LA.
    J Clin Endocrinol Metab; 1985 Feb; 60(2):370-5. PubMed ID: 3917460
    [Abstract] [Full Text] [Related]

  • 10. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Awouters M, Verbruggen W, Schetz M, Verwaest C, Lauwers P, Bouillon R, Bowers CY.
    J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
    [Abstract] [Full Text] [Related]

  • 11. Impaired inhibitory effects of somatostatin on growth hormone (GH)-releasing hormone stimulation of GH secretion after short term infusion.
    Kelijman M, Frohman LA.
    J Clin Endocrinol Metab; 1990 Jul; 71(1):157-63. PubMed ID: 1973420
    [Abstract] [Full Text] [Related]

  • 12. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N, Evans WS, Bowers CY, Veldhuis JD.
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
    [Abstract] [Full Text] [Related]

  • 13. Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time-dependent effect.
    Rosenthal SM, Kaplan SL, Grumbach MM.
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1101-5. PubMed ID: 2498383
    [Abstract] [Full Text] [Related]

  • 14. Dual effects of growth hormone (GH)-releasing hormone infusion in normal men: somatotroph desensitization and increase in releasable GH.
    Vance ML, Kaiser DL, Rivier J, Vale W, Thorner MO.
    J Clin Endocrinol Metab; 1986 Mar; 62(3):591-4. PubMed ID: 3080467
    [Abstract] [Full Text] [Related]

  • 15. Lack of in vivo somatotroph desensitization or depletion after 14 days of continuous growth hormone (GH)-releasing hormone administration in normal men and a GH-deficient boy.
    Vance ML, Kaiser DL, Martha PM, Furlanetto R, Rivier J, Vale W, Thorner MO.
    J Clin Endocrinol Metab; 1989 Jan; 68(1):22-8. PubMed ID: 2491864
    [Abstract] [Full Text] [Related]

  • 16. Acute growth hormone (GH) response to GH-releasing hexapeptide in humans is independent of endogenous GH-releasing hormone.
    Robinson BM, Friberg RD, Bowers CY, Barkan AL.
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1121-4. PubMed ID: 1400881
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Growth hormone (GH) responses to the hexapeptide GH-releasing peptide and GH-releasing hormone (GHRH) in the cynomolgus macaque: evidence for non-GHRH-mediated responses.
    Malozowski S, Hao EH, Ren SG, Marin G, Liu L, Southers JL, Merriam GR.
    J Clin Endocrinol Metab; 1991 Aug; 73(2):314-7. PubMed ID: 1856262
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.